MBS8400255 | Anti-CD19 (Inebilizumab); Humanized Antibody

Anti-CD19 (Inebilizumab); Humanized Antibody | MBS8400255 | Mybiosource

Product Short Name: [CD19]

Product Name Synonyme: [MEDI-551; MEDI 551; MEDI551; B4; CVID3; CD19 Molecule; B-Lymphocyte Surface Antigen B4; T-Cell Surface Antigen Leu-12; Differentiation Antigen CD19; B-Lymphocyte Antigen CD19; CD19 Antigen]

Other Names: N/A

Product Gene Name: [CD19]

Product Gene Name Synonyme: N/A

Other Gene Names: N/A

Clonality: Monoclonal

Isotype: IgG1; kappa

Clone: N/A

Host: Human

Reactivity: Human

Specificity: The biosimilar is a humanized afucosylated monoclonal antibody that specifically targets CD19 and causes antibody-dependent cellular cytolysis

Purity: Protein A purified

Form: Colorless liquid. In PBS; pH7.5

Concentration: 1mg/ml

Storage Stability: Store at -80 degree C. The antibody solution should be gently mixed before use.
Shipping: Gel Pack
Shelf Life: Est.~12 months
Country of Origin: USA

Tested Application: N/A